Posts
- How does the luciferin luciferase system work? (October 20, 2021)
- What is D-luciferin? (October 18, 2021)
- What is D-luciferin used for? (October 18, 2021)
- Research Grade Antibody Biosimilars (October 23, 2021)
- Buffer recipe for plasmid miniprep by spin columns (October 23, 2021)
- Cytokines (October 24, 2021)
- Enzymes & Kinases (October 24, 2021)
- How to make D-luciferin potassium salt? (October 20, 2021)
- Immune Checkpoints (October 24, 2021)
- Special Discount for Taq DNA Polymerase (December 3, 2021)
- PD1 Proteins, Antibodies, Inhibitors, and Constructs (March 5, 2022)
- Mouse IgG Isotype Control Antibodies (October 28, 2021)
- Human IgG Isotype Control Antibodies (October 27, 2021)
Products
- Rabbit Polyclonal Antibody Production Services (October 12, 2021)
- ELISA Guaranteed Mouse Monoclonal Antibody production + Standard Peptide Synthesis + Peptide Conjugation (October 13, 2021)
- ELISA Guaranteed Mouse Monoclonal Antibody production (October 13, 2021)
- Standard Rabbit Polyclonal Antibody Production Service + Standard Peptide Synthesis + Peptide Conjugation (October 12, 2021)
- Standard Rabbit Polyclonal Antibody Production Service (October 12, 2021)
- Spin Column for Gel Extraction (October 13, 2021)
- Guaranteed Mouse Monoclonal Antibody Production Services (October 13, 2021)
- Cloning and Sequencing Antibody VH and VL (CDR Analysis Included; Leader Sequences Available) of Samples with Dominant Truncated Sequences + Transient Production and Purification of Recombinant IgG + Antigen-antibody Binding Confirmation by ELISA (October 24, 2021)
- Cloning and Sequencing Antibody VH and VL (CDR Analysis Included; Leader Sequences Available) of Samples with Dominant Truncated Sequences (October 24, 2021)
- Cloning and Sequencing of Full Length Antibody (CDR Analysis Included; Leader Sequences Available) (October 24, 2021)
- Cloning and Sequencing of Antibody VH and VL + Transient Production and Purification of Recombinant IgG + Antigen-antibody Binding Confirmation by ELISA (October 24, 2021)
- Cloning and Sequencing Antibody VH and VL (CDR Analysis Included; Leader Sequences Available) (October 24, 2021)
- In Vivo Grade Recombinant Human IgG4-S228P L235E P329G (SPLEPG) Isotype Control Antibody (October 25, 2021)
- In Vivo Grade Recombinant Human IgG4-S228P Isotype Control Antibody (October 25, 2021)
- In Vivo Grade Recombinant Mouse IgG2a Isotype Control Antibody (October 25, 2021)
- In Vivo Grade Recombinant Mouse IgG1-D265A Isotype Control Antibody (October 25, 2021)
- In Vivo Grade Recombinant Mouse IgG1 Isotype Control Antibody (October 25, 2021)
- In Vivo Grade Recombinant Mouse IgG2c-L234A L235A P329G (LALAPG) Isotype Control Antibody (October 25, 2021)
- In Vivo Grade Recombinant Mouse IgG2c Isotype Control Antibody (October 25, 2021)
- In Vivo Grade Recombinant Mouse IgG2a-L234A L235A P329G (LALAPG) Isotype Control Antibody (October 25, 2021)
- In Vivo Grade Recombinant Mouse IgG2a-N297A Isotype Control Antibody (October 25, 2021)
- In Vivo Grade Recombinant Mouse IgG2a-D265A Isotype Control Antibody (October 25, 2021)
- In Vivo Grade Recombinant Human IgG1-L234A L235A P329G (LALAPG) Isotype Control Antibody (October 25, 2021)
- In Vivo Grade Recombinant Human IgG1-N297A Isotype Control Antibody (October 25, 2021)
- In Vivo Grade Recombinant Human IgG1-D265A Isotype Control Antibody (October 25, 2021)
- Protein A Beads (October 26, 2021)
- Magnetic Microbead Conjugated DYKDDDDK-Tag Antibody (October 26, 2021)
- Agarose Conjugated DYKDDDDK-Tag Antibody (October 26, 2021)
- Magnetic Microbead Conjugated Anti-Human Fc Antibody (October 26, 2021)
- BCMA / CD269 / TNFRSF17 Nanobodies (October 26, 2021)
- HA-Tag Antibody (October 26, 2021)
- Myc-Tag Antibody (October 26, 2021)
- RFP Antibody (October 26, 2021)
- GH Antibody (October 26, 2021)
- DYKDDDDK-Tag Antibody (October 26, 2021)
- DYKDDDDK-Tag Antibody (October 26, 2021)
- GAPDH Antibody (October 26, 2021)
- GFP Antibody (October 26, 2021)
- GST-Tag Antibody (October 26, 2021)
- In Vivo Grade Recombinant Human IgG1 Fc-N297A Protein (October 27, 2021)
- In Vivo Grade Recombinant Human IgG1 Fc-D265A Protein (October 27, 2021)
- SARS-CoV-2 IgG ELISA Kit (N Protein) (October 26, 2021)
- SARS-CoV-2 IgG ELISA Kit (S Protein) (October 26, 2021)
- Recombinant SARS Spike S1-Fc-Avi Protein (October 26, 2021)
- Recombinant SARS-CoV-2 Spike S1-Fc-Avi Protein (October 26, 2021)
- Recombinant SARS Spike S1-His-Avi Protein (October 26, 2021)
- Recombinant SARS-CoV-2 Spike S1-His-Avi Protein (October 26, 2021)
- Biotinylated Recombinant SARS Spike S1-Fc-Avi Protein (October 26, 2021)
- Biotinylated Recombinant SARS Spike S1-His-Avi Protein (October 26, 2021)
- Biotinylated Recombinant SARS-CoV-2 Spike S1-Fc-Avi Protein (October 26, 2021)
- Biotinylated Recombinant SARS-CoV-2 Spike S1 Protein (October 26, 2021)
- Recombinant SARS-CoV-2 Spike RBD (October 26, 2021)
- Biotinylated Recombinant SARS-CoV-2 Spike RBD-Fc-Avi (October 26, 2021)
- Biotinylated Recombinant SARS-CoV-2 Spike RBD-Fc-Avi (October 26, 2021)
- Biotinylated Recombinant SARS-CoV-2 Spike RBD-His-Avi (October 26, 2021)
- Recombinant Human ACE2 Protein (October 26, 2021)
- Recombinant Cyno ACE2-His-Avi Protein (October 26, 2021)
- Recombinant Human ACE2-His-Avi Protein (October 26, 2021)
- Biotinylated Recombinant Cyno ACE2-His-Avi Protein (October 26, 2021)
- Recombinant SARS-CoV-2 Spike S-Fc Protein (October 26, 2021)
- Biotinylated Recombinant Human ACE2-Fc-Avi Protein (October 26, 2021)
- Biotinylated Recombinant Human ACE2-His-Avi Protein (October 26, 2021)
- Recombinant SARS-CoV-2 Nucleocapsid Protein (October 26, 2021)
- Recombinant SARS Spike RBD-Fc-Avi (October 26, 2021)
- Recombinant SARS Spike RBD-His-Avi (October 26, 2021)
- Biotinylated Recombinant SARS Spike RBD-Fc-Avi (October 26, 2021)
- Biotinylated Recombinant SARS Spike RBD-His-Avi (October 26, 2021)
- Biotinylated Recombinant SARS-CoV-2 Spike S-His-Avi Protein (October 26, 2021)
- Recombinant SARS-CoV-2 Spike S-His-Avi Protein (October 26, 2021)
- 2x PCR PreMix (Red Dye) (October 27, 2021)
- 2x PCR PreMix (Blue Dye) (October 27, 2021)
- 10 mM dNTP Mixes (October 27, 2021)
- PCR Master Mixes (Green) (October 27, 2021)
- MMLV RT Enzyme (October 27, 2021)
- First Strand cDNA Synthesis Kit (October 27, 2021)
- Spin Column for PCR Product Cleanup (October 13, 2021)
- Spin Column for Plasmid Miniprep (October 13, 2021)
- One-step RT-PCR Kit (October 27, 2021)
- Two-step RT-PCR Kit (October 27, 2021)
- PCR Enhancer (October 27, 2021)
- Blood Direct PCR Kit (October 27, 2021)
- Cell and Tissue Direct PCR Kit (October 27, 2021)
- Long Taq PCR Master Mixes (October 27, 2021)
- 100 mM dNTP Mixes and Sets (October 27, 2021)
- High Yield PCR Master Mix (October 27, 2021)
- High Yield Taq DNA Polymerases (October 27, 2021)
- In Vivo Grade Recombinant Human IgG1 Fc-L234A L235A P329G (LALAPG) Protein (October 27, 2021)
- AZ5104 (October 27, 2021)
- AZD-0156 (AZD0156) (October 28, 2021)
- AZD8330 (October 28, 2021)
- In Vivo Grade Recombinant Human IgG2 Isotype Control Antibody (October 26, 2021)
- In Vivo Grade Recombinant Mouse IgG2b Isotype Control Antibody (October 26, 2021)
- In Vivo Grade Recombinant Rat IgG2a Isotype Control Antibody (October 26, 2021)
- In Vivo Grade Recombinant Rat IgG2c Isotype Control Antibody (October 26, 2021)
- In Vivo Grade Recombinant Rat IgG2b Isotype Control Antibody (October 25, 2021)
- In Vivo Grade Recombinant Rat IgG1 Isotype Control Antibody (October 25, 2021)
- In Vivo Grade Recombinant Human IgG1 Fc Protein (October 27, 2021)
- In Vivo Grade Recombinant Human IgG2 Fc Protein (October 27, 2021)
- In Vivo Grade Recombinant Human IgG4 Fc Protein (October 27, 2021)
- In Vivo Grade Recombinant Mouse IgG1 Fc Protein (October 27, 2021)
- BYL719 (ALPELISIB) (October 28, 2021)
- GEMCITABINE (FREE BASE) (October 28, 2021)
- DABRAFENIB (FREE BASE) (October 28, 2021)
- DABRAFENIB MESYLATE (October 28, 2021)
- GS-9901 (October 28, 2021)
- LGX818 (ENCORAFENIB) (October 28, 2021)
- LOXO-195 (SELITRECTINIB) (October 28, 2021)
- LOXO-292 (SELPERCATINIB) (October 28, 2021)
- LXS-196 (NVP-LXS196) (October 28, 2021)
- LY2835219 (ABEMACICLIB) (FREE BASE) (October 28, 2021)
- LOXO-101 (LAROTRECTINIB) (October 28, 2021)
- LEE011 (RIBOCICLIB) (October 28, 2021)
- LDK378 (CERITINIB) (October 28, 2021)
- In Vivo Grade Recombinant Human IgG1 Isotype Control Antibody (October 25, 2021)
- In Vivo Grade Recombinant Human IgG1-D265A N297A Isotype Control Antibody (October 25, 2021)
- In Vivo Grade Recombinant Human IgG1-S267E L328F (SELF) Isotype Control Antibody (October 25, 2021)
- M2698 (MSC2363318A) (October 30, 2021)
- MK-2206 MONOHYDROCHLORIDE (1 X HCL SALT) (October 30, 2021)
- SARS-CoV-2 Nucleocapsid Nanobodies (October 26, 2021)
- SARS-CoV-2 Spike RBD Monoclonal Antibody (October 26, 2021)
- SCH900353 (MK-8353) (October 31, 2021)
- TORIN 2 (October 31, 2021)
- PCI-27483 (November 1, 2021)
- D-Luciferin Potassium Salt (October 22, 2021)
- AZD4547 (October 28, 2021)
- IACS-010759 (IACS-10759) (November 2, 2021)
- LY-3381916 (November 2, 2021)
- MLN7243 (TAK-243, AOB 87172) (November 2, 2021)
- PD-1 INHIBITOR 16 (AURIGENE COMPOUND 16) (November 2, 2021)
- MLN4924 (PEVONEDISTAT) (November 2, 2021)
- PBF-509 (TAMINADENANT) (November 2, 2021)
- TAK-981 (November 2, 2021)
- AZD7762 (October 28, 2021)
- LHC-165 (November 3, 2021)
- RMC-4550 (RMC4550) (November 3, 2021)
- EPZ-5676 (PINOMETOSTAT) (November 3, 2021)
- GSK923295 (November 1, 2021)
- IFN alpha 2a Protein (November 3, 2021)
- IACS-010759 (IACS-10759) (November 2, 2021)
- EED-226 (EED226) (November 2, 2021)
- DOCETAXEL (November 2, 2021)
- GSK923295 (November 2, 2021)
- EPZ-5676 (PINOMETOSTAT) (November 2, 2021)
- EPZ005687 (November 2, 2021)
- EPZ011989 (November 2, 2021)
- LCL-161 (November 2, 2021)
- VORINOSTAT (November 2, 2021)
- JQ1, (+) (November 2, 2021)
- GEMCITABINE (HCL SALT) (November 2, 2021)
- VALSARTAN (November 2, 2021)
- EPROSARTAN MESYLATE (November 2, 2021)
- ROMIDEPSIN (November 2, 2021)
- PYRIDOSTATIN (November 2, 2021)
- SR-4370 (November 2, 2021)
- RG7388 (IDASANUTLIN) (November 2, 2021)
- YM155 (November 2, 2021)
- NVP-CGM097 (FREE BASE) (November 2, 2021)
- E-7386 (E7386) (November 2, 2021)
- PF-06840003 (EOS-200271) (November 2, 2021)
- EPACADOSTAT (November 2, 2021)
- VX-765 (November 2, 2021)
- VARESPLADIB SODIUM (LY315920 SODIUM SALT) (November 2, 2021)
- VARESPLADIB METHYL (LY333013) (November 2, 2021)
- HA130 (November 2, 2021)
- ENZALUTAMIDE (November 2, 2021)
- ODANACATIB (November 2, 2021)
- VARESPLADIB (LY315920) (November 2, 2021)
- GDC-0449 (VISMODEGIB) (November 2, 2021)
- NVP-LDE225 DIPHOSPHATE SALT (ERISMODEGIB, SONIDEGIB) (November 2, 2021)
- I-BET762 (MOLIBRESIB) (GSK525762) (November 2, 2021)
- LBH-589 (November 2, 2021)
- MGCD0103 (November 2, 2021)
- MS-275 (November 2, 2021)
- OTX-015 (BIRABRESIB) (November 2, 2021)
- TUBACIN (November 2, 2021)
- NVP-AUY922 (November 2, 2021)
- I-BET726 (GSK1324726A) (November 1, 2021)
- GSK3326595 (EPZ015938) (November 1, 2021)
- GSK3368715 (EPZ019997) (November 1, 2021)
- I-BET151 (GSK1210151A) -- OPTICALLY PURE SOURCE (November 1, 2021)
- GSK2879552 (November 1, 2021)
- GSK126 (November 1, 2021)
- EPZ-6438 (TAZEMETOSTAT) (November 1, 2021)
- DOXORUBICIN (November 1, 2021)
- DECITABINE (November 1, 2021)
- 5-AZACITIDINE (November 1, 2021)
- WEHI-539 (November 1, 2021)
- S63845 (S-63845) (November 1, 2021)
- OBATOCLAX (November 1, 2021)
- MIK665 (S64315) (November 1, 2021)
- WT161 (WT-161) (November 1, 2021)
- PF-8380 (November 1, 2021)
- TUBASTATIN A (November 1, 2021)
- PBF-509 (TAMINADENANT) (November 1, 2021)
- XL765 (VOXTALISIB, SAR245409) (November 1, 2021)
- XL-228 (November 1, 2021)
- XL184 (CABOZANTINIB) (FREE BASE) (November 1, 2021)
- XL-147 (November 1, 2021)
- ZM447439 (November 1, 2021)
- WZ4002 (October 31, 2021)
- VX-702 (October 31, 2021)
- VX-680 (October 31, 2021)
- VX-11E (October 31, 2021)
- VS-4718 (PND-1186) (October 31, 2021)
- AZD3965 (October 31, 2021)
- VOLITINIB (AZD6094, SAVOLITINIB) (October 31, 2021)
- VE-822 (BERZOSERTIB) (October 31, 2021)
- VATALANIB (October 31, 2021)
- VANDETANIB (October 31, 2021)
- UPROSERTIB (GSK2141795) (October 31, 2021)
- ULIXERTINIB (BVD-523, VRT752271) (October 31, 2021)
- TGX-221 (October 31, 2021)
- TG101348 (FEDRATINIB, SAR302503) (October 31, 2021)
- TG100-115 (October 31, 2021)
- TANDUTINIB (October 31, 2021)
- TAK-931 (SIMUROSERTIB) (October 31, 2021)
- TAK-632 (October 31, 2021)
- TAE226 (NVP-TAE226) (October 31, 2021)
- SORAFENIB (FREE BASE) (October 31, 2021)
- SERABELISIB (MLN1117, INK1117, TAK-117) (October 31, 2021)
- SCH900776 (MK-8776) (October 31, 2021)
- SCH772984 (October 31, 2021)
- SAPANISERTIB (TAK-228) (MLN0128) (October 31, 2021)
- RN486 (RN-486) (October 31, 2021)
- REGORAFENIB (October 31, 2021)
- RDEA119 (REFAMETINIB) (October 31, 2021)
- PP242 (October 31, 2021)
- PONATINIB ( 2 X HCL SALT) (October 30, 2021)
- PLX4720 (October 30, 2021)
- PLX4032 (October 30, 2021)
- PF-04691502 (October 30, 2021)
- PF-04217903 (October 30, 2021)
- PF-03758309 (October 30, 2021)
- PF-02341066 (October 30, 2021)
- PD-0325901 (October 30, 2021)
- PCI-32765 (IBRUTINIB) (October 30, 2021)
- PAZOPANIB (October 30, 2021)
- PALBOCICLIB (PD-0332991) (ISETHIONATE SALT) (October 30, 2021)
- PALBOCICLIB (PD-0332991) (HCL SALT) (October 30, 2021)
- PALBOCICLIB (PD-0332991) (FREE BASE) (October 30, 2021)
- OSI-027 (October 30, 2021)
- OTS-964 (November 2, 2021)
- OLMUTINIB (BI 1482694, HM71224) (October 30, 2021)
- NVP-TAE684 (October 30, 2021)
- NVP-BKM120 (BUPARLISIB) (October 30, 2021)
- NVP-BHG712 (BHG-712) (October 30, 2021)
- NMS1286937 (NMS-P937) (October 30, 2021)
- NILOTINIB (October 30, 2021)
- MOTESANIB DIPHOSPHATE (October 30, 2021)
- NVP-BGJ398 (INFIGRATINIB) (October 30, 2021)
- NVP-BEZ235 (October 30, 2021)
- MOTESANIB (FREE BASE) (October 30, 2021)
- MLN8237 (October 30, 2021)
- MK-5108 (October 30, 2021)
- MK-2206 DIHYDROCHLORIDE SALT (2XHCL SALT) (October 30, 2021)
- LY-3295668 (AK-01) (October 30, 2021)
- MK-1775 (ADAVOSERTIB) (AZD1775) (October 30, 2021)
- MGCD516 (SITRAVATINIB) (October 30, 2021)
- MGCD265 (GLESATINIB) (October 30, 2021)
- LY-3214996 (LY3214996) (October 30, 2021)
- LY-3200882 (LY3200882) (October 30, 2021)
- LY-3177833 (LY3177833) (October 30, 2021)
- LY294002 (October 30, 2021)
- LY-2606368 (PREXASERTIB) DIHYDROCHLORIDE (October 28, 2021)
- LAPATINIB (FREE BASE) (October 28, 2021)
- LAPATINIB (DITOSYLATE SALT) (October 28, 2021)
- IPI-549 (October 28, 2021)
- IPI-145 (October 28, 2021)
- INCB018424 (RUXOLITINIB) (October 28, 2021)
- IC-87114 (October 28, 2021)
- GSK690693 (October 28, 2021)
- GSK461364 (October 28, 2021)
- GSK2982772 (October 28, 2021)
- GSK2636771 (October 28, 2021)
- GSK2334470 (October 28, 2021)
- GSK2256098 (October 28, 2021)
- GSK2126458 (OMIPALISIB) (October 28, 2021)
- GSK1120212 (TRAMETINIB) (October 28, 2021)
- GSK-1070916 (NMI-900) (October 28, 2021)
- GS-9973 (ENTOSPLETINIB) (October 28, 2021)
- GS-4997 (SELONSERTIB) (October 28, 2021)
- GNE-7915 (October 28, 2021)
- GLPG-0634 (FILGOTINIB) (October 28, 2021)
- GILTERITINIB (ASP2215) (October 28, 2021)
- GEFITINIB (October 28, 2021)
- GDC-0994 (RAVOXERTINIB, RG7842) (October 28, 2021)
- GDC-0980 (October 28, 2021)
- GDC-0973 (COBIMETINIB) (October 28, 2021)
- GDC-0941 (FREE BASE) (October 28, 2021)
- GDC-0068 (October 28, 2021)
- GDC-0032 (TASELISIB) (October 28, 2021)
- FRAX486 (October 28, 2021)
- FORETINIB (October 28, 2021)
- EVEROLIMUS (October 28, 2021)
- ERLOTINIB (October 28, 2021)
- EMD1214063 (TEPOTINIB) (October 28, 2021)
- DINACICLIB (October 28, 2021)
- Trastuzumab Biosimilar, L234A L235A P329G (LALAPG) Fc Silent Mutant (October 26, 2021)
- Pertuzumab Biosimilar, Anti-human HER2 Monoclonal Antibody (October 25, 2021)
- Cetuximab Biosimilar, L234A L235A P329G (LALAPG) Fc Silent Mutant (October 26, 2021)
- Panitumumab Biosimilar, Anti-human EGFR Monoclonal Antibody (October 25, 2021)
- Denosumab Biosimilar, Anti-human RANKL Monoclonal Antibody (October 25, 2021)
- Palivizumab Biosimilar, L234A L235A P329G (LALAPG) Fc Silent Mutant (October 26, 2021)
- Omalizumab Biosimilar, L234A L235A P329G (LALAPG) Fc Silent Mutant (October 26, 2021)
- Denosumab Biosimilar, L234A L235A P329G (LALAPG) Fc Silent Mutant (October 26, 2021)
- Ranibizumab Biosimilar, Anti-human VEGF Monoclonal Antibody (Fab) (October 25, 2021)
- Paclitaxel (Taxol) (November 2, 2021)
- Hypothemycin (October 28, 2021)
- Nimotuzumab Biosimilar, Anti-human EGFR Monoclonal Antibody (November 9, 2021)
- Matuzumab Biosimilar, Anti-human EGFR Monoclonal Antibody (November 8, 2021)
- Pertuzumab Biosimilar, L234A L235A P329G (LALAPG) Fc Silent Mutant (October 26, 2021)
- Panitumumab Biosimilar, L234A L235A P329G (LALAPG) Fc Silent Mutant (October 26, 2021)
- Eculizumab Biosimilar, Anti-human C5 Monoclonal Antibody (October 25, 2021)
- Eculizumab Biosimilar, L234A L235A P329G (LALAPG) Fc Silent Mutant (October 26, 2021)
- TAK-931 (SIMUROSERTIB) (November 3, 2021)
- Daratumumab Biosimilar, Anti-human CD38 Monoclonal Antibody (November 4, 2021)
- M-3258 (M3258, M 3258) (November 2, 2021)
- Antibody Sequencing Service (October 24, 2021)
- Daclizumab Biosimilar, Anti-human CD25 Monoclonal Antibody (November 8, 2021)
- Obinutuzumab Biosimilar, Anti-human CD20 Monoclonal Antibody (November 9, 2021)
- Sarilumab Biosimilar, Anti-human IL-6R Monoclonal Antibody (November 4, 2021)
- Natalizumab Biosimilar, Anti-human Integrin alpha 4 (α4) Monoclonal Antibody (November 9, 2021)
- Adalimumab Biosimilar, Anti-human TNF alpha Monoclonal Antibody (October 25, 2021)
- Infliximab Biosimilar, L234A L235A P329G (LALAPG) Fc Silent Mutant (October 26, 2021)
- Alemtuzumab Biosimilar, Anti-human CD52 Monoclonal Antibody (November 8, 2021)
- Bevacizumab Biosimilar, L234A L235A P329G (LALAPG) Fc Silent Mutant (October 26, 2021)
- Bevacizumab Biosimilar, Anti-human VEGF Monoclonal Antibody (October 25, 2021)
- Briakinumab Biosimilar, Anti-human IL-12 / IL-23 Monoclonal Antibody (November 8, 2021)
- Clenoliximab Biosimilar, Anti-human CD4 Monoclonal Antibody (November 8, 2021)
- Drozitumab Biosimilar, Anti-human TRAIL Monoclonal Antibody (November 8, 2021)
- Efalizumab Biosimilar, Anti-human CD11a Monoclonal Antibody (November 8, 2021)
- Epratuzumab Biosimilar, Anti-human CD22 Monoclonal Antibody (November 8, 2021)
- Felvizumab Biosimilar, Anti-RSV Monoclonal Antibody (November 8, 2021)
- Palivizumab Biosimilar, Anti-RSV Monoclonal Antibody (October 25, 2021)
- Galiximab Biosimilar, Anti-human CD80 Monoclonal Antibody (November 8, 2021)
- Gemtuzumab Biosimilar, Anti-human CD33 Monoclonal Antibody (November 8, 2021)
- Infliximab Biosimilar, Anti-human TNF alpha Monoclonal Antibody (October 25, 2021)
- Minretumomab Biosimilar, Anti-human TAG-72 Monoclonal Antibody (November 8, 2021)
- Mogamulizumab Biosimilar, Anti-human CCR4 Monoclonal Antibody (November 9, 2021)
- Muromonab Biosimilar, Anti-human CD3 Monoclonal Antibody (November 9, 2021)
- Omalizumab Biosimilar, Anti-human IgE Monoclonal Antibody (October 25, 2021)
- Rituximab Biosimilar, Anti-human CD20 Monoclonal Antibody (October 25, 2021)
- Rituximab Biosimilar, L234A L235A P329G (LALAPG) Fc Silent Mutant (October 26, 2021)
- Secukinumab Biosimilar, Anti-human IL-17A Monoclonal Antibody (November 5, 2021)
- Tabalumab Biosimilar, Anti-human BAFF Monoclonal Antibody (November 8, 2021)
- Tocilizumab Biosimilar, Anti-human IL-6R Monoclonal Antibody (November 4, 2021)
- Ustekinumab Biosimilar, Anti-human IL-12/IL-23 Monoclonal Antibody (November 8, 2021)
- SARS-CoV-2 Spike S1 Rabbit Monoclonal Antibody (October 26, 2021)
- In Vivo Grade Recombinant Hamster IgG2 Isotype Control Antibody (October 26, 2021)
- Abciximab Biosimilar, Anti-human Glycoprotein IIb/IIIa Receptor Monoclonal Antibody (November 8, 2021)
- Nivolumab Biosimilar, Anti-Human PD-1 Monoclonal Antibody (November 3, 2021)
- Ipilimumab Biosimilar, Anti-Human CTLA-4 Monoclonal Antibody (November 8, 2021)
- Lorlatinib (PF-06463922) (October 30, 2021)
- Atezolizumab Biosimilar, Anti-human PD-L1 Monoclonal Antibody (November 3, 2021)
- Durvalumab Biosimilar, Anti-human PD-L1 Monoclonal Antibody (November 3, 2021)
- Pembrolizumab Biosimilar, Anti-human PD-1 Monoclonal Antibody (November 3, 2021)
- Camrelizumab Biosimilar, Anti-human PD-1 Monoclonal Antibody (November 4, 2021)
- Cemiplimab Biosimilar, Anti-human PD-1 Monoclonal Antibody (November 4, 2021)
- Spartalizumab Biosimilar, Anti-human PD-1 Monoclonal Antibody (November 5, 2021)
- Tremelimumab Biosimilar, Anti-human CTLA-4 Monoclonal Antibody (November 8, 2021)
- ND-646 (November 29, 2021)
- Batefenterol (GSK-961081) (November 29, 2021)
- In Vivo Grade Recombinant Syrian Hamster IgG1 Isotype Control Antibody (November 27, 2021)
- Etoposide phosphate (BMY-40481) (November 18, 2021)
- Glumetinib (SCC244) (November 18, 2021)
- KB-0742 dihydrochloride (KB0742) (November 18, 2021)
- GSK046 (GSK-046, IBET-BD2) (November 18, 2021)
- BI-3406 (November 17, 2021)
- Giredestrant (GDC-9545) (November 17, 2021)
- Brolucizumab Biosimilar, Anti-human VEGFA Monoclonal Antibody (November 11, 2021)
- Isatuximab Biosimilar, Anti-human CD38 Monoclonal Antibody (November 11, 2021)
- Volociximab Biosimilar, Anti-human Integrin α5β1 Monoclonal Antibody (November 9, 2021)
- Toralizumab Biosimilar, Anti-human CD40L Monoclonal Antibody (November 9, 2021)
- Zalutumumab Biosimilar, Anti-human EGFR Monoclonal Antibody (November 9, 2021)
- Satumomab Biosimilar, Anti-human TAG-72 Monoclonal Antibody (November 9, 2021)
- Ruplizumab Biosimilar, Anti-human CD40L Monoclonal Antibody (November 9, 2021)
- Relatlimab Biosimilar, Anti-human LAG-3 Monoclonal Antibody (November 9, 2021)
- Ramucirumab Biosimilar, Anti-human VEGFR-2 Monoclonal Antibody (November 9, 2021)
- Pateclizumab Biosimilar, Anti-human LT alpha (LT-α) Monoclonal Antibody (November 9, 2021)
- Pascolizumab Biosimilar, Anti-human IL-4 Monoclonal Antibody (November 9, 2021)
- Oxelumab Biosimilar, Anti-human CD252 Monoclonal Antibody (November 9, 2021)
- AVN944 (VX-944, AVN-944) (November 1, 2021)
- Ozanimod (RPC-1063) (December 8, 2021)
- BEC hydrochloride (December 8, 2021)
- DEL-22379 (December 10, 2021)
- Tirabrutinib (ONO-4059, GS-4059) (December 10, 2021)
- JNJ-4796 (December 10, 2021)
- Nazartinib (EGF-816) (December 10, 2021)
- BLU-9931 (December 12, 2021)
- PRT-060318 (PRT318, P142–76) (December 14, 2021)
- Vactosertib (EW-7197, TEW-7197) (December 16, 2021)
- M-2698 (MSC2363318A) (November 2, 2021)
- Darovasertib (LXS-196, NVP-LXS196, IDE196) (November 2, 2021)
- LYC-55716 (CINTIRORGON) (November 2, 2021)
- AMG-232 (November 1, 2021)
- ALTIRATINIB (DCC-2701) (November 3, 2021)
- A-1155463 (November 2, 2021)
- A-1210477 (November 1, 2021)
- A-769662 (November 3, 2021)
- AB-680 (November 1, 2021)
- ABT-199 (November 3, 2021)
- ABT-199 (VENETOCLAX) (November 1, 2021)
- ABT-263 (November 3, 2021)
- ABT-263 (NOVITOCLAX) (November 1, 2021)
- ABT-737 (November 1, 2021)
- AC220 (QUIZARTINIB) (November 3, 2021)
- ACALABRUTINIB (ACP196) (November 3, 2021)
- ADU-S100 (November 2, 2021)
- AFURESERTIB (GSK2110183) (November 3, 2021)
- AG-120 (IVOSIDENIB) (November 2, 2021)
- AG-221 (ENASIDENIB) (November 2, 2021)
- AHU-377 (SACUBITRIL) (November 2, 2021)
- AMG-176 (November 2, 2021)
- AMG-176 (AMG176) (November 1, 2021)
- AMG-337 (November 3, 2021)
- AMG-511 (November 3, 2021)
- AN2728 (CRISABOROLE) (November 2, 2021)
- APREMILAST (November 2, 2021)
- AP26113 (BRIGATINIB) (November 2, 2021)
- ARQ-197 (November 2, 2021)
- ARRY-162 (BINIMETINIB, MEK162) (November 3, 2021)
- ARV-825 (November 2, 2021)
- AS-605240 (November 3, 2021)
- AS-703026 (PIMASERTIB) (November 3, 2021)
- ASN-002 (GUSACITINIB) (November 3, 2021)
- ASP3026 (November 3, 2021)
- ATORVASTATIN CALCIUM (November 2, 2021)
- AV-951 (TIVOZANIB) (November 3, 2021)
- AZD-4205 (AZD4205) (October 28, 2021)
- AZD0530 (October 28, 2021)
- AZD3458 (AZD-3458) (October 28, 2021)
- AZD3463 (October 28, 2021)
- AZD4320 (AZD-4320) (November 5, 2021)
- AZD4573 (AZD-4573) (October 28, 2021)
- AZD5363 (October 28, 2021)
- AZD5582 (November 2, 2021)
- AZD5991 (AZD-5991) (November 1, 2021)
- AZD6244 (SELUMETINIB) (October 28, 2021)
- AZD8055 (October 28, 2021)
- AZD8186 (October 28, 2021)
- AZD9291 (OSIMERTINIB) (October 28, 2021)
- BAY-1082439 (October 28, 2021)
- BAY-1436032 (November 2, 2021)
- BAY-1816032 (BAY1816032) (October 28, 2021)
- BAY-1895344 (BAY1895344) (October 28, 2021)
- BCL-201 (S55746) (November 1, 2021)
- BELINOSTAT (October 30, 2021)
- BELVARAFENIB (GDC-5573) (HM95573) (October 28, 2021)
- BEXAROTENE (November 2, 2021)
- BGB-283 (LIFIRAFENIB) (October 28, 2021)
- BI 2536 (October 28, 2021)
- BI 6727 (VOLASERTIB) (October 28, 2021)
- BIRINAPANT (November 2, 2021)
- BLU-667 (PRALSETINIB) (BLU667) (October 28, 2021)
- BMN-673 (TALAZOPARIB) (MDV-3800) (LT 00673) (November 2, 2021)
- BMS-777607 (October 28, 2021)
- BMS-911543 (October 28, 2021)
- AVL-292 (SPEBRUTINIB) (November 3, 2021)
- AZD1152-HQPA (October 28, 2021)
- AZD1152 (BARASERTIB) (October 28, 2021)
- AZD1480 (October 28, 2021)
- AZD2014 (VISTUSERTIB) (October 28, 2021)
- AZD4635 (HTL-1071) (November 1, 2021)
- BAY-1251152 (BAY 1251152) (October 28, 2021)
- BIBW-2992 (AFATINIB) (October 28, 2021)
- CAL-101 (October 28, 2021)
- CC-671 (October 28, 2021)
- CB-839 (TELAGLENASTAT) (November 1, 2021)
- CB-1158 (INCB01158) (November 1, 2021)
- CCS-1477 (CCS1477) (November 2, 2021)
- CCT-245737 (PNT-737) (November 2, 2021)
- CCT196969 (October 28, 2021)
- CEP-28122 (October 28, 2021)
- CEP-28122 MESYLATE (October 28, 2021)
- CEP-37440 (October 28, 2021)
- CFI-400945 (October 28, 2021)
- CGAMP, SODIUM SALT (October 28, 2021)
- CGS-21680 (November 1, 2021)
- CH5424802 (October 28, 2021)
- CRENOLANIB (October 28, 2021)
- COMPOUND 7 (HCL SALT) (November 2, 2021)
- CO-1686 (ROCILETINIB) (October 28, 2021)
- CNDAC (DFP-10917, TAS-109) (November 2, 2021)
- CUDC-101 (October 28, 2021)
- CUDC-305 (DEBIO-0932) (November 2, 2021)
- CVT-6883 (November 1, 2021)
- CYC-116 (October 28, 2021)
- CYT-387 (MOMELOTINIB) (October 28, 2021)
- DACOMITINIB (October 28, 2021)
- DARAPLADIB (SB-480848) (November 2, 2021)
- DASATINIB (October 28, 2021)
- DBET1 (November 2, 2021)
- DCC-2036 (REBASTINIB) (October 28, 2021)
- DECERNOTINIB (VX-509) (October 28, 2021)
- DEFACTINIB (VS-6063, PF-04554878) (October 28, 2021)
- Trastuzumab Biosimilar, Human IgG2 (March 30, 2022)
- Trastuzumab Biosimilar, N297A Mutant (March 30, 2022)
- Trastuzumab Biosimilar, Human IgG3 (March 30, 2022)
- Trastuzumab Biosimilar, Human IgG4 S228P Mutant (March 30, 2022)
- Trastuzumab Biosimilar, Human IgA2 (March 31, 2022)
- Trastuzumab Biosimilar, Mouse IgG1 (March 31, 2022)
- Atezolizumab Biosimilar, Human IgG1 (March 31, 2022)
- Atezolizumab Biosimilar, Human IgG4 S228P Mutant (March 31, 2022)
- Adalimumab Biosimilar, L234A L235A P329G (LALAPG) Fc Silent Mutant (October 26, 2021)
- Denosumab Biosimilar, Human IgG1 (March 31, 2022)
- Cetuximab Biosimilar, N297A Mutant (March 31, 2022)
- Cetuximab Biosimilar, Human IgG2 (March 31, 2022)
- Cetuximab Biosimilar, Human IgG3 (March 31, 2022)
- Cetuximab Biosimilar, Mouse IgG2 (March 31, 2022)
- Cetuximab Biosimilar, Mouse IgG1 (March 31, 2022)
- Cetuximab Biosimilar, Human IgA2 (March 31, 2022)
- Cetuximab Biosimilar, Human IgG4 S228P Mutant (March 31, 2022)
- Ipilimumab Biosimilar, Human IgG4 S228P Mutant (March 31, 2022)
- Nivolumab Biosimilar, Human IgG1 (March 31, 2022)
- Rituximab Biosimilar, N297A Mutant (March 31, 2022)
- Rituximab Biosimilar, Human IgG2 (March 31, 2022)
- Rituximab Biosimilar, Human IgG3 (March 31, 2022)
- Rituximab Biosimilar, Human IgG4 S228P Mutant (March 31, 2022)
- Rituximab Biosimilar, Human IgA2 (March 31, 2022)
- Rituximab Biosimilar, Mouse IgG1 (March 31, 2022)
- Rituximab Biosimilar, Mouse IgG2 (March 31, 2022)
- In Vivo Grade Recombinant Rabbit IgG Fc Protein (March 31, 2022)
- In Vivo Grade Recombinant Human IgG3 Fc Protein (March 31, 2022)
- In Vivo Grade Recombinant Rat IgG2b Fc Protein (March 31, 2022)
- In vivo Grade Recombinant HyHEL-10 Mouse IgG1 Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant HEL D1.3 Mouse IgG1 Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant MOPC-21 Mouse IgG1 Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant B1-8 Mouse IgG1 Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant HEL D1.3 Mouse IgG2a Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant HEL D1.3 Mouse IgG2b Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant HEL D1.3 Mouse IgG2c Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant HEL D1.3 Mouse IgG3 Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant HEL D1.3 Mouse Fab Fragment (March 31, 2022)
- In vivo Grade Recombinant HEL D1.3 Human IgG1 Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant HEL D1.3 Human IgG2 Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant HEL D1.3 Human IgG3 Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant HEL D1.3 Human IgG4-S228P Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant HEL D1.3 Human Fab Fragment (March 31, 2022)
- In vivo Grade Recombinant HEL D1.3 Human IgE Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant HEL D1.3 Human IgM Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant HEL D1.3 Human IgA1 Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant HEL D1.3 Rat IgG1 Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant HEL D1.3 Rat IgG2a Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant HEL D1.3 Rat IgG2b Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant HEL D1.3 Rat IgG2c Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant HEL D1.3 Rat Fab Fragment (March 31, 2022)
- In vivo Grade Recombinant HEL D1.3 Hamster IgG1 Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant HEL D1.3 Hamster IgG2 Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant HEL D1.3 Rabbit IgG Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant HEL D1.3 Ferret IgM Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant HEL D1.3 Ferret IgA Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant HEL D1.3 Canine IgG1 Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant HEL D1.3 Canine IgG2 Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant HEL D1.3 Canine IgG3 Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant HEL D1.3 Feline IgG1 Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant HEL D1.3 Canine IgG4 Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant HyHEL-10 Mouse IgG2a Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant HyHEL-10 Mouse IgG2b Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant HyHEL-10 Mouse IgG2c Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant HyHEL-10 Mouse IgG3 Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant HyHEL-10 Human IgG1 Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant HyHEL-10 Human IgG2 Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant HyHEL-10 Human IgG3 Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant HyHEL-10 Human IgG4-S228P Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant HyHEL-10 Rat IgG1 Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant HyHEL-10 Rat IgG2a Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant HyHEL-10 Rat IgG2b Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant HyHEL-10 Rat IgG2c Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant HyHEL-10 Hamster IgG1 Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant HyHEL-10 Hamster IgG2 Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant HyHEL-10 Rabbit IgG Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant HyHEL-10 Mouse Fab Fragment (March 31, 2022)
- In vivo Grade Recombinant HyHEL-10 Human Fab Fragment (March 31, 2022)
- In vivo Grade Recombinant HyHEL-10 Rat Fab Fragment (March 31, 2022)
- In vivo Grade Recombinant HyHEL-10 Human IgE Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant HyHEL-10 Human IgM Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant HyHEL-10 Human IgA1 Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant HyHEL-10 Ferret IgG1 Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant HyHEL-10 Ferret IgM Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant HyHEL-10 Ferret IgA Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant HyHEL-10 Canine IgG1 Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant HyHEL-10 Canine IgG2 Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant HyHEL-10 Canine IgG3 Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant HyHEL-10 Canine IgG4 Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant HyHEL-10 Feline IgG1 Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant MOPC-21 Mouse IgG2a Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant MOPC-21 Mouse IgG2b Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant MOPC-21 Mouse IgG2c Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant MOPC-21 Mouse IgG3 Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant MOPC-21 Human IgG1 Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant MOPC-21 Human IgG2 Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant MOPC-21 Human IgG3 Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant MOPC-21 Mouse IgG1 Isotype Control Antibody (Copy) (March 31, 2022)
- In vivo Grade Recombinant MOPC-21 Rat IgG1 Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant MOPC-21 Rat IgG2a Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant MOPC-21 Rat IgG2b Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant MOPC-21 Rat IgG2c Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant MOPC-21 Hamster IgG1 Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant MOPC-21 Hamster IgG2 Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant MOPC-21 Rabbit IgG Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant MOPC-21 Mouse Fab Fragment (March 31, 2022)
- In vivo Grade Recombinant MOPC-21 Human Fab Fragment (March 31, 2022)
- In vivo Grade Recombinant MOPC-21 Rat Fab Fragment (March 31, 2022)
- In vivo Grade Recombinant MOPC-21 Human IgE Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant MOPC-21 Human IgM Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant MOPC-21 Human IgA1 Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant MOPC-21 Ferret IgG1 Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant MOPC-21 Ferret IgM Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant MOPC-21 Ferret IgA Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant MOPC-21 Canine IgG1 Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant MOPC-21 Canine IgG2 Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant MOPC-21 Canine IgG3 Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant MOPC-21 Canine IgG4 Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant MOPC-21 Feline IgG1 Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant C1.18.4 Mouse IgG2a Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant C1.18.4 Mouse IgG2b Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant C1.18.4 Mouse IgG2c Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant C1.18.4 Mouse IgG3 Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant C1.18.4 Mouse IgG1 Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant C1.18.4 Mouse Fab Fragment (March 31, 2022)
- In vivo Grade Recombinant C1.18.4 Human Fab Fragment (March 31, 2022)
- In vivo Grade Recombinant C1.18.4 Rat Fab Fragment (March 31, 2022)
- In vivo Grade Recombinant C1.18.4 Human IgG1 Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant C1.18.4 Human IgG4-S228P Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant C1.18.4 Rat IgG1 Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant C1.18.4 Rat IgG2a Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant C1.18.4 Rat IgG2b Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant C1.18.4 Rat IgG2c Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant C1.18.4 Hamster IgG1 Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant C1.18.4 Hamster IgG2 Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant C1.18.4 Rabbit IgG Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant C1.18.4 Human IgG2 Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant C1.18.4 Human IgG3 Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant C1.18.4 Human IgE Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant C1.18.4 Human IgM Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant C1.18.4 Human IgA1 Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant C1.18.4 Ferret IgG1 Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant C1.18.4 Ferret IgM Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant C1.18.4 Ferret IgA Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant C1.18.4 Canine IgG1 Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant C1.18.4 Canine IgG3 Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant C1.18.4 Canine IgG4 Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant C1.18.4 Feline IgG1 Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant B1-8 Mouse IgG2a Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant B1-8 Mouse IgG2b Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant B1-8 Mouse IgG2c Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant B1-8 Mouse IgG3 Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant B1-8 Human IgG1 Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant B1-8 Human IgG2 Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant B1-8 Human IgG3 Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant B1-8 Human IgG4-S228P Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant B1-8 Rat IgG1 Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant B1-8 Rat IgG2a Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant B1-8 Rat IgG2b Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant B1-8 Rat IgG2c Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant B1-8 Hamster IgG1 Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant B1-8 Rabbit IgG Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant B1-8 Hamster IgG2 Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant B1-8 Mouse Fab Fragment (March 31, 2022)
- In vivo Grade Recombinant B1-8 Human Fab Fragment (March 31, 2022)
- In vivo Grade Recombinant B1-8 Rat Fab Fragment (March 31, 2022)
- In vivo Grade Recombinant B1-8 Human IgE Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant B1-8 Human IgM Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant B1-8 Human IgA1 Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant B1-8 Ferret IgG1 Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant B1-8 Ferret IgM Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant B1-8 Ferret IgA Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant B1-8 Canine IgG1 Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant B1-8 Canine IgG2 Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant B1-8 Canine IgG3 Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant B1-8 Canine IgG4 Isotype Control Antibody (March 31, 2022)
- In vivo Grade Recombinant B1-8 Feline IgG1 Isotype Control Antibody (March 31, 2022)
- In Vivo Grade Recombinant Hamster IgG2 Isotype Control Antibody (March 31, 2022)
- In Vivo Grade Recombinant Hamster IgG1 Isotype Control Antibody (March 31, 2022)
- In Vivo Grade Recombinant Rat IgG2a Fc Protein (March 31, 2022)
- In Vivo Grade Recombinant Llama IgG2b Fc Protein (March 31, 2022)
- In Vivo Grade Recombinant Mouse IgG2a Fc Protein (March 31, 2022)
- In Vivo Grade Recombinant Mouse IgG2b Fc Protein (March 31, 2022)
- RTA-408 (Omaveloxolone) (November 30, 2021)
- Trastuzumab Biosimilar, HER2 Monoclonal Antibody (October 25, 2021)
- Trastuzumab Biosimilar, Mouse IgG2a (March 31, 2022)
- Pembrolizumab Biosimilar, Human IgG1 (March 31, 2022)
- In Vivo Grade Recombinant Armenian Hamster IgG1 Isotype Control Antibody (October 26, 2021)
- In vivo Grade Recombinant Anti-mouse CD25 Mouse IgG2c Kappa Monoclonal Antibody (March 2, 2023)
- In vivo Grade Recombinant Afucosylated Anti-mouse CD25 Mouse IgG2c Kappa Monoclonal Antibody (March 2, 2023)
- In vivo Grade Recombinant Anti-mouse CD25 rat IgG1 Lamda Monoclonal Antibody (March 2, 2023)
- In vivo Grade Recombinant Anti-mouse CD25 Rabbit IgG Monoclonal Antibody (March 2, 2023)
- In vivo Grade Recombinant Anti-mouse CD25 Mouse Fab Fragment (March 2, 2023)
- In vivo Grade Recombinant Anti-Human HER2/ErbB-2/c-neu Mouse IgG1 monoclonal Antibody (March 2, 2023)
- In vivo Grade Recombinant Anti-Human HER2/ErbB-2/c-neu Mouse IgG2a monoclonal Antibody (March 2, 2023)
- In vivo Grade Recombinant Anti-Human HER2/ErbB-2/c-neu Mouse IgG2b monoclonal Antibody (March 2, 2023)
- In vivo Grade Recombinant Anti-Human HER2/ErbB-2/c-neu Mouse IgG2c monoclonal Antibody (March 2, 2023)
- In vivo Grade Recombinant Anti-Human HER2/ErbB-2/c-neu Mouse IgG3 monoclonal Antibody (March 2, 2023)
- In vivo Grade Recombinant Anti-Human HER2/ErbB-2/c-neu Mouse IgG1-D265A monoclonal Antibody (March 2, 2023)
- In vivo Grade Recombinant Anti-Human HER2/ErbB-2/c-neu Mouse IgG2a-D265A monoclonal Antibody (March 2, 2023)
- In vivo Grade Recombinant Anti-Human HER2/ErbB-2/c-neu Mouse IgG2a-N297A monoclonal Antibody (March 2, 2023)
- In vivo Grade Recombinant Anti-Human HER2/ErbB-2/c-neu Mouse IgG2a-L234A L235A P329G (LALAPG) monoclonal Antibody (March 2, 2023)
- In vivo Grade Recombinant Anti-Human HER2/ErbB-2/c-neu Rat IgG1 monoclonal Antibody (March 2, 2023)
- In vivo Grade Recombinant Anti-Human HER2/ErbB-2/c-neu Rat IgG2a monoclonal Antibody (March 2, 2023)
- In vivo Grade Recombinant Anti-Human HER2/ErbB-2/c-neu Rat IgG2b monoclonal Antibody (March 2, 2023)
- In vivo Grade Recombinant Anti-Human HER2/ErbB-2/c-neu Rat IgG2c monoclonal Antibody (March 2, 2023)
- In vivo Grade Recombinant Anti-Human HER2/ErbB-2/c-neu Mouse Fab Fragment (March 2, 2023)
- In vivo Grade Recombinant Anti-DYKDDDDK-Tag Human IgG1 Monoclonal Antibody (Clone M2.1) (March 2, 2023)
- Recombinant Anti-DYKDDDDK-Tag Mouse IgG1 Monoclonal Antibody (Clone M2.1) (March 2, 2023)
- Recombinant Anti-DYKDDDDK-Tag Mouse IgG2b Monoclonal Antibody (Clone M2.1) (March 2, 2023)
- Recombinant Anti-DYKDDDDK-Tag Mouse IgG2a Monoclonal Antibody (Clone M2.1) (March 2, 2023)
- Recombinant Anti-DYKDDDDK-Tag Mouse IgG2c Monoclonal Antibody (Clone M2.1) (March 2, 2023)
- Recombinant Anti-DYKDDDDK-Tag Mouse IgG3 Monoclonal Antibody (Clone M2.1) (March 2, 2023)
- Recombinant Anti-DYKDDDDK-Tag Mouse Fab Fragment (Clone M2.1) (March 2, 2023)
- Recombinant Anti-DYKDDDDK-Tag Human IgG2 Monoclonal Antibody (Clone M2.1) (March 2, 2023)
- Recombinant Anti-DYKDDDDK-Tag Human IgG3 Monoclonal Antibody (Clone M2.1) (March 2, 2023)
- Recombinant Anti-DYKDDDDK-Tag Human IgG4-S228P Monoclonal Antibody (Clone M2.1) (March 2, 2023)
- Recombinant Anti-DYKDDDDK-Tag Human Fab Fragment (Clone M2.1) (March 2, 2023)
- Recombinant Anti-DYKDDDDK-Tag Rat IgG1 Monoclonal Antibody (Clone M2.1) (March 2, 2023)
- Recombinant Anti-DYKDDDDK-Tag Rat IgG2a Monoclonal Antibody (Clone M2.1) (March 2, 2023)
- Recombinant Anti-DYKDDDDK-Tag Rat IgG2b Monoclonal Antibody (Clone M2.1) (March 2, 2023)
- Recombinant Anti-DYKDDDDK-Tag Rat IgG2c Monoclonal Antibody (Clone M2.1) (March 2, 2023)
- Recombinant Anti-DYKDDDDK-Tag Rat Fab Fragment (Clone M2.1) (March 2, 2023)
- Recombinant Anti-DYKDDDDK-Tag Rabbit IgG Monoclonal Antibody (Clone M2.1) (March 2, 2023)
- Recombinant Anti-Myc-Tag Mouse IgG1 Monoclonal Antibody (Clone 9E10) (March 2, 2023)
- Recombinant Anti-Myc-Tag Mouse IgG1 Monoclonal Antibody (Clone 9E10) (March 2, 2023)
- Recombinant Anti-Myc-Tag Mouse IgG2a Monoclonal Antibody (Clone 9E10) (March 2, 2023)
- Recombinant Anti-Myc-Tag Mouse IgG2c Monoclonal Antibody (Clone 9E10) (March 2, 2023)
- Recombinant Anti-Myc-Tag Mouse IgG3 Monoclonal Antibody (Clone 9E10 (March 2, 2023)
- Recombinant Anti-Myc-Tag Rat IgG1 Monoclonal Antibody (Clone 9E10) (March 2, 2023)
- Recombinant Anti-Myc-Tag Rat IgG2a Monoclonal Antibody (Clone 9E10) (March 2, 2023)
- Recombinant Anti-Myc-Tag Rat IgG2b Monoclonal Antibody (Clone 9E10) (March 2, 2023)
- Recombinant Anti-Myc-Tag Rabbit IgG Monoclonal Antibody (Clone 9E10) (March 2, 2023)
- Recombinant Anti-Myc-Tag Mouse Fab Fragment (Clone 9E10) (March 2, 2023)
- Recombinant Anti-Myc-Tag Human Fab Fragment (Clone 9E10) (March 2, 2023)
- Recombinant Anti-Myc-Tag Rat Fab Fragment (Clone 9E10) (March 2, 2023)
- In vivo Grade Recombinant Anti-DNP Mouse IgG1 Isotype Control Antibody (March 2, 2023)
- In vivo Grade Recombinant Anti-DNP Mouse IgG2a Isotype Control Antibody (March 2, 2023)
- In vivo Grade Recombinant Anti-DNP Mouse IgG2b Isotype Control Antibody (March 2, 2023)
- In vivo Grade Recombinant Anti-DNP Mouse IgG2c Isotype Control Antibody (March 2, 2023)
- In vivo Grade Recombinant Anti-DNP Mouse IgG3 Isotype Control Antibody (March 2, 2023)
- In vivo Grade Recombinant Anti-DNP Human IgG1 Isotype Control Antibody (March 2, 2023)
- In vivo Grade Recombinant Anti-DNP Human IgG2 Isotype Control Antibody (March 2, 2023)
- In vivo Grade Recombinant Anti-DNP Human IgG3 Isotype Control Antibody (March 2, 2023)
- In vivo Grade Recombinant Anti-DNP Human IgG4-S228P Isotype Control Antibody (March 2, 2023)
- In vivo Grade Recombinant Anti-DNP Rat IgG1 Isotype Control Antibody (March 2, 2023)
- In vivo Grade Recombinant Anti-DNP Rat IgG2a Isotype Control Antibody (March 2, 2023)
- In vivo Grade Recombinant Anti-DNP Rat IgG2b Isotype Control Antibody (March 2, 2023)
- In vivo Grade Recombinant Anti-DNP Rat IgG2c Isotype Control Antibody (March 2, 2023)
- In vivo Grade Recombinant Anti-DNP Hamster IgG1 Isotype Control Antibody (March 2, 2023)
- In vivo Grade Recombinant Anti-DNP Hamster IgG2 Isotype Control Antibody (March 2, 2023)
- In vivo Grade Recombinant Anti-DNP Rabbit IgG Isotype Control Antibody (March 2, 2023)
- In vivo Grade Recombinant Anti-DNP Mouse Fab Fragment (March 2, 2023)
- In vivo Grade Recombinant Anti-DNP Human Fab Fragment (March 2, 2023)
- In vivo Grade Recombinant Anti-DNP Rat Fab Fragment (March 2, 2023)
- In vivo Grade Recombinant Anti-DNP Human IgE Isotype Control Antibody (March 2, 2023)
- In vivo Grade Recombinant Anti-DNP Human IgM Isotype Control Antibody (March 2, 2023)
- In vivo Grade Recombinant Anti-DNP Human IgA1 Isotype Control Antibody (March 2, 2023)
- In vivo Grade Recombinant Anti-DNP Ferret IgG1 Isotype Control Antibody (March 2, 2023)
- In vivo Grade Recombinant Anti-DNP Ferret IgM Isotype Control Antibody (March 2, 2023)
- In vivo Grade Recombinant Anti-DNP Ferret IgA Isotype Control Antibody (March 2, 2023)
- In vivo Grade Recombinant Anti-DNP Canine IgG2 Isotype Control Antibody (March 2, 2023)
- In vivo Grade Recombinant Anti-DNP Canine IgG3 Isotype Control Antibody (March 2, 2023)
- In vivo Grade Recombinant Anti-DNP Canine IgG4 Isotype Control Antibody (March 2, 2023)
- In vivo Grade Recombinant Anti-DNP Feline IgG1 Isotype Control Antibody (March 2, 2023)
- Avelumab Biosimilar, Anti-human PD-L1 Monoclonal Antibody (November 3, 2021)
- In vivo Grade Recombinant Anti-DNP Hamster IgG1 Monoclonal Antibody (March 2, 2023)
- In vivo Grade Recombinant Anti-DNP Human Fab Fragment (March 2, 2023)
- In vivo Grade Recombinant Anti-DNP Rabbit IgG Monoclonal Antibody (March 2, 2023)
- In vivo Grade Recombinant Anti-DNP Rat IgG2a Monoclonal Antibody (March 2, 2023)
- In vivo Grade Recombinant Anti-DNP Human IgG1 Monoclonal Antibody (March 2, 2023)
- In vivo Grade Recombinant Anti-DNP Mouse IgG2a Monoclonal Antibody (March 2, 2023)
- In vivo Grade Recombinant Anti-DNP Mouse Fab Fragment (March 2, 2023)
- In vivo Grade Recombinant Anti-DNP Rat Fab Fragment (March 2, 2023)
- In vivo Grade Recombinant Anti-DNP Ferret IgG1 Monoclonal Antibody (March 2, 2023)
- In vivo Grade Recombinant Anti-DNP Canine IgG1 Isotype Control Antibody (March 2, 2023)
- In vivo Grade Recombinant Anti-DNP Feline IgG1 Monoclonal Antibody (March 2, 2023)
- In vivo Grade Recombinant Anti-DNP Canine IgG1 Monoclonal Antibody (March 2, 2023)
- In Vivo Grade Recombinant Anti-mouse PD-L1 Mouse IgG1-D265A Kappa Monoclonal Antibody (Clone 10F.9G2.1) (March 1, 2023)
- In Vivo Grade Recombinant Anti-mouse PD-L1 Mouse IgG2c Kappa Monoclonal Antibody (Clone 10F.9G2.1) (March 1, 2023)
- In Vivo Grade Recombinant Anti-mouse PD-L1 Mouse IgG1 Kappa Monoclonal Antibody (Clone 10F.9G2.1) (March 1, 2023)
- In Vivo Grade Recombinant Anti-mouse PD-L1 Mouse IgG2a Kappa Monoclonal Antibody (Clone 10F.9G2.1) (March 1, 2023)
- In Vivo Grade Recombinant Anti-mouse PD-L1 Mouse IgG2a-L234A L235A P329G (LALAPG) Kappa Monoclonal Antibody (Clone 10F.9G2.1) (March 1, 2023)
- In Vivo Grade Recombinant Anti-mouse PD-L1 Rat IgG2b Kappa Monoclonal Antibody (Clone 10F.9G2.1) (March 1, 2023)
- In Vivo Grade Recombinant Anti-mouse PD-L1 Rabbit IgG Monoclonal Antibody (Clone 10F.9G2.1) (March 1, 2023)
- In Vivo Grade Recombinant Anti-mouse PD-1 Mouse IgG2c Kappa Monoclonal Antibody (Clone 29F.1A12.1) (March 1, 2023)
- In Vivo Grade Recombinant Anti-mouse PD-1 Rabbit IgG Monoclonal Antibody (Clone 29F.1A12.1) (March 1, 2023)
- In Vivo Grade Recombinant Anti-mouse PD-1 Mouse IgG1-D265A Kappa Monoclonal Antibody (Clone 29F.1A12.1) (March 1, 2023)
- In Vivo Grade Recombinant Anti-mouse PD-1 Mouse IgG1 Kappa Monoclonal Antibody (Clone 29F.1A12.1) (March 1, 2023)
- In Vivo Grade Recombinant Anti-mouse PD-1 Rat IgG2a Kappa Monoclonal Antibody (Clone 29F.1A12.1) (March 1, 2023)
- In Vivo Grade Recombinant Anti-mouse PD-1 Mouse IgG2a-L234A L235A P329G (LALAPG) Kappa Monoclonal Antibody (Clone 29F.1A12.1) (March 1, 2023)
- In Vivo Grade Recombinant Anti-mouse PD-1 Mouse IgG2a Kappa Monoclonal Antibody (Clone 29F.1A12.1) (March 1, 2023)
- In Vivo Grade Recombinant Murinized Anti-mouse PD-1 Mouse IgG2a Kappa Monoclonal Antibody (Clone RMP1-14.1) (March 1, 2023)
- In Vivo Grade Recombinant Murinized Anti-mouse PD-1 Mouse IgG1-D265A Kappa Monoclonal Antibody (Clone RMP1-14.1) (March 1, 2023)
- In Vivo Grade Recombinant Murinized Anti-mouse PD-1 Mouse IgG1 Kappa Monoclonal Antibody (Clone RMP1-14.1) (March 1, 2023)
- In Vivo Grade Recombinant Murinized Anti-mouse PD-1 Mouse IgG2a-L234A L235A P329G (LALAPG) Kappa Monoclonal Antibody (Clone RMP1-14.1) (March 1, 2023)
- In Vivo Grade Recombinant Anti-mouse PD-1 Rabbit IgG Monoclonal Antibody (Clone RMP1-14.1) (March 1, 2023)
- In Vivo Grade Recombinant Anti-mouse PD-1 Mouse IgG2c Kappa Monoclonal Antibody (Clone RMP1-14.1) (March 1, 2023)
- In Vivo Grade Recombinant Anti-mouse PD-1 Mouse IgG1 Kappa Monoclonal Antibody (Clone RMP1-14.1) (March 1, 2023)
- In Vivo Grade Recombinant Anti-mouse PD-1 Mouse IgG2a-L234A L235A P329G (LALAPG) Kappa Monoclonal Antibody (Clone RMP1-14.1) (March 1, 2023)
- In Vivo Grade Recombinant Anti-mouse PD-1 Mouse IgG2a Kappa Monoclonal Antibody (Clone RMP1-14.1) (March 1, 2023)
- In Vivo Grade Recombinant Anti-mouse PD-1 Mouse IgG1-D265A Kappa Monoclonal Antibody (Clone RMP1-14.1) (March 1, 2023)
- Taq DNA Polymerases (October 27, 2021)
- Cetuximab Biosimilar, Anti-human EGFR Monoclonal Antibody (October 25, 2021)
- In Vivo Grade Recombinant Anti-mouse PD-1 Rat IgG2a Kappa Monoclonal Antibody (Clone RMP1-14.1) (March 1, 2023)
Categories
Tags
- luciferin luciferase reaction mechanism
- L-luciferin
- oxidation of D-luciferin
- D-Luciferin
- Luciferase
- Firefly Luciferin
- D-Luciferin Sodium Salt
- in vivo animal research
- D-Luciferin Potassium Salt
- research grade antibody biosimilar
- antibody
- antibody biosimilar
- antibody biosimilar research grade
- spin column for plasmid miniprep
- spin column for DNA extraction
- Cytokines
- luciferin injection mice
- In vivo luciferase imaging protocol
- Luciferin stock solution
- IVIS luciferin
- PD-L1
- Immune Checkpoint
- PD1
- CTLA4
- Taq enzyme
- dNTP mix
- Taq polymerase
- Taq DNA polymerase
- mouse PD1 protein
- anti-human PD1 antibody
- human PD1 protein
- anti-mouse PD1 antibody
- mIgG2a isotype control antibody
- mIgG1 Fc protein
- mouse IgG2a isotype control antibody
- hIgG1 Fc protein
- hIgG1 Isotype Control Antibody
- Isotype Control Antibody
- Human IgG1 Isotype Control Antibody
Product categories
Product tags
- spin column for gel extraction
- Hybridoma
- spin column for PCR product cleanup
- spin column
- Spin column for plasmid miniprep
- Spin column for DNA extraction
- plasmid purification
- RT-PCR
- PCR enhancer
- direct PCR
- dNTP
- PCR PreMix
- PCR Master Mix
- Fc protein
- hIgG1 Fc
- hIgG1
- AZ5104
- AZD0156
- Human IgG1 Isotype Control
- hIgG1 isotype control
- isotype control antibody
- SARS-CoV-2 spike RBD antibody
- 2019-nCoV spike RBD antibody
- RBD monoclonal antibody
- Clone # CR3022
- luciferin
- Firefly luciferin
- luciferase
- D-Luciferin Potassium Salt
- FGFR inhibitor
- ABSK091
- AZD-4547
- AZD4547
- research grade Pertuzumab Biosimilar
- ErbB-2 Monoclonal Antibody
- research grade panitumumab biosimilar
- RANKL monoclonal antibody
- RANKL
- RANK ligand
- research grade ranibizumab biosimilar
- C5 monoclonal antibody
- human C5 monoclonal antibody
- C5
- Cell Division Cycle 7
- SIMUROSERTIB
- TAK931
- TAK-931
- CDC7
- CDC7 Kinase Inhibitor
- CAS No. 1330782-76-7
- glycoprotein
- immunoproteasome subunit
- LMP7
- immunoproteasome subunit LMP7 (β5i) inhibitor
- CAS No. 2285330-15-4
- CAS 2285330-15-4
- M3258
- β5i
- M-3258
- antibody sequencing service
- hybridoma sequencing service
- single B cell antibody sequencing service
- CD25
- CD25 monoclonal antibody
- interleukin 6 receptor
- ITGA4
- human cd52 monoclonal antibody
- cd52 monoclonal antibody
- cd52
- research grade Bevacizumab biosimilar
- CD4
- CD4 monoclonal antibody
- TRAIL
- CD11a monoclonal antibody
- CD11a
- ITGAL
- CD22 monoclonal antibody
- SIGLEC
- CD22
- respiratory syncytial virus
- RSV monoclonal antibody
- RSV
- CD80
- CD80 monoclonal antibody
- cd33 monoclonal antibody
- cd33
- research grade TNF alpha biosimilar
- CCR4 monoclonal antibody
- CCR4
- CD3 monoclonal antibody
- CD3
- IgE monoclonal antibody
- IgE
- IL-17A
- IL-17A monoclonal antibody
- biosimilar
- BAFF
- BAFF monoclonal antibody
- TNFSF13B
- IL-6R
- IL6
- IL-12
- IL23
- IL12
- IL-23
- Glycoprotein IIIa Receptor
- Glycoprotein IIb Receptor
- Glycoprotein IIb/IIIa Receptor
- ROS1 inhibitor
- PF-06463922 supplier
- ALK inhibitor
- PF-06463922
- Lorlatinib
- CAS NO. 1454846-35-5
- CAS 1454846-35-5
- PF-06463922 cheap
- PF-06463922 price
- PF-06463922 sigma
- PF-06463922 purchase
- PDL1 monoclonal antibody
- CD279
- CD152 Monoclonal Antibody
- Acetyl-CoA Carboxylase
- CAS No. 1434639-57-2
- ACC
- ND-646
- CAS 1434639-57-2
- ND646
- Steric Inhibitor
- Adrenoceptor Agonist
- CAS 743461-65-6
- Muscarinic Receptor
- GSK-961081
- TD-5959
- CAS No. 743461-65-6
- β2-Adrenoceptor Agonist
- Batefenterol
- β2-Adrenoceptor
- Muscarinic Receptor Antagonist
- topoisomerase II
- topoisomerase
- topoisomerase II inhibitor
- BMY40481
- BMY-40481
- CAS No 117091-64-2
- CAS 117091-64-2
- Etoposide
- Etoposide phosphate
- CAS No. 1642581-63-2
- ATP-competitive
- c-met inhibitor
- ATP-competitive c-Met inhibitor
- CAS 1642581-63-2
- SCC-244
- SCC244
- c-met
- Glumetinib
- Cyclin-dependent kinase 9
- CDK9 inhibitor
- CDK9
- KB0742
- KB-0742
- CAS No.: 2416874-75-2
- BRD4
- IBET-BD2
- GSK-046
- GSK046
- BRDT
- bromodomain
- BRD3
- BRD2
- CAS No: 2474876-09-8
- BET proteins
- CAS No: 2230836-55-0
- BI-3406
- KRAS
- Son of Sevenless 1
- SOS1-KRAS interaction inhibitor
- KRAS-SOS1 interaction inhibitor
- SOS1
- BI3406
- ER ligand
- CAS No.: 1953133-47-5
- estrogen receptor
- GDC-9545
- Giredestrant
- VEGF-A
- Human VEGF Monoclonal Antibody
- CD38 monoclonal antibody
- CD38
- fibronectin
- integrin
- CD154
- CD40 ligand
- TAG-72 monoclonal antibody
- TAG-72
- CD40L monoclonal antibody
- CD40L
- LAG-3 monoclonal antibody
- LAG-3
- LAG3
- VEGFR-2 monoclonal antibody
- VEGFR
- lymphotoxin alpha
- IL-4
- IL-4 monoclonal antibody
- IL4
- CD252
- OX40L
- TNFSF4
- IMPDH2
- Inosine Monophosphate Dehydrogenase
- IMPDH
- CAS 297730-17-7
- IMPDH1
- CAS No. 297730-17-7
- VX944
- VX-944
- AVN-944
- AVN944
- RPC-1063
- Ozanimod Bulk Order
- Ozanimod Order
- Ozanimod Supplier
- Ozanimod Purchase
- CAS 11306760-87-1
- CAS No. 11306760-87-1
- Ozanimod
- Ozanimod Bulk
- RPC1063
- 222638-67-7 supplier
- BEC
- BEC HCl
- BEC hydrochloride
- CAS No. 222638-67-7
- CAS 222638-67-7
- BEC purchase
- 222638-67-7 purchase
- BEC supplier
- Arginase II inhibitor
- DEL22379
- DEL-22379
- DEL-22379 supplier
- DEL-22379 price
- DEL-22379 order
- CAS No. 181223-80-3
- CAS 181223-80-3
- 181223-80-3 supplier
- 181223-80-3 price
- DEL-22379 purchase
- CAS 1351636-18-4
- ONO-4059 purchase
- ONO-4059 supplier
- ONO-4059 price
- BTK inhibitor
- 1351636-18-4 supplier
- 1351636-18-4 price
- Tirabrutinib purchase
- CAS No. 1351636-18-4
- GS-4059 purchase
- GS-4059 supplier
- Tirabrutinib
- Tirabrutinib price
- ONO-4059
- GS-4059 price
- GS-4059
- Tirabrutinib supplier
- JNJ-4796 price
- 2241664-16-2 price
- CAS 2241664-16-2 purchase
- JNJ-4796 supplier
- CAS 2241664-16-2
- CAS No. 2241664-16-2
- 2241664-16-2 supplier
- CAS 2241664-16-2 supplier
- 2241664-16-2 purchase
- JNJ-4796 order
- JNJ-4796
- JNJ4796
- JNJ-4796 purchase
- influenza virus inhibitor
- EGF-816 price
- Nazartinib purchase
- Nazartinib
- EGF-816 supplier
- EGF816 purchase
- EGF816 price
- EGF816 order
- EGF816 supplier
- EGF816
- EGF-816
- Nazartinib price
- Nazartinib supplier
- Nazartinib order
- CAS No. 1508250-71-2
- CAS 1508250-71-2 purchase
- CAS 1508250-71-2 price
- CAS 1508250-71-2 supplier
- 1508250-71-2 supplier
- 1508250-71-2 purchase
- 1508250-71-2 price
- CAS 1508250-71-2
- FGFR4
- BLU-9931 supplier
- BLU-9931 purchase
- BLU-9931
- fibroblast growth factor receptor 4
- fibroblast growth factor receptor 4 inhibitor
- CAS 1538604-68-0 price
- 1538604-68-0 supplier
- 1538604-68-0 purchase
- 1538604-68-0 Price
- CAS 1538604-68-0 supplier
- CAS 1538604-68-0 purchase
- CAS 1538604-68-0
- CAS No. 1538604-68-0
- BLU-9931 price
- FGFR4 inhibitor
- 1194961-19-7 supplier
- P142–76
- 1194961-19-7 price
- 1194961-19-7 purchase
- CAS No. 1194961-19-7
- CAS 1194961-19-7
- syk inhibitor
- spleen tyrosine kinase inhibitor
- PRT318 price
- PRT318 purchase
- PRT318 supplier
- PRT-060318 supplier
- PRT-060318 price
- PRT-060318 purchase
- PRT-060318
- Vactosertib purchase
- Vactosertib supplier
- Vactosertib
- Vactosertib price
- EW-7197 purchase
- CAS 1352608-82-2
- CAS No. 1352608-82-2
- 1352608-82-2 supplier
- 1352608-82-2 price
- 1352608-82-2 purchase
- ALK5 inhibitor
- ATP-competitive activin receptor-like kinase 5 inhibitor
- EW-7197 price
- EW-7197 supplier
- EW-7197
- TEW-7197 purchase
- TEW-7197 supplier
- TEW-7197 price
- TEW-7197
- M-2698 price
- 1379545-95-5 price
- M-2698 purchase
- M-2698 supplier
- MSC2363318A
- 1379545-95-5 supplier
- 1379545-95-5 purchase
- M2698
- akt inhibitor
- CAS No. 1379545-95-5
- p70S6K inhibitor
- M-2698
- CAS 1379545-95-5 supplier
- CAS 1379545-95-5 purchase
- CAS 1379545-95-5 price
- CAS 1379545-95-5
- CAS 1874276-76-2
- PKC inhibitor
- protein kinase C inhibitor
- 1874276-76-2 purchase
- 1874276-76-2 price
- CAS No. 1874276-76-2
- CAS 1874276-76-2 supplier
- IDE-196
- Darovasertib price
- LXS-196 supplier
- Darovasertib
- Darovasertib purchase
- 1874276-76-2 supplier
- Darovasertib supplier
- LXS-196 purchase
- LXS-196 price
- LXS-196
- 2055536-64-4 price
- CAS No. 2055536-64-4 purchase
- CAS 2055536-64-4
- CAS No. 2055536-64-4
- 2055536-64-4 supplier
- 2055536-64-4 purchase
- Cintirorgon price
- Cintirorgon supplier
- Cintirorgon purchase
- Cintirorgon
- LYC-55716 price
- LYC-55716 purchase
- LYC-55716
- LYC-55716 supplier
- CAS No. 2055536-64-4 supplier
- RORγ agonist
- Adalimumab
- TNF alpha monoclonal antibody
- Human EGFR Monoclonal Antibody
- CTLA-4
- Human CTLA-4 Monoclonal Antibody
- CTLA-4 Monoclonal Antibody
- research grade ipilimumab biosimilar
- research grade nivolumab biosimilar
- cd20 monoclonal antibody
- cd20
- synthetic triterpenoid
- AIM
- triterpenoid
- NO
- Nuclear Factor Erythroid 2-Related Factor 2
- Nrf2
- Antioxidant Inflammation Modulator
- nitric oxide
- Kelch-like ECH-associated Protein 1
- RTA-408
- CAS 1474034-05-3
- CAS NO. 1474034-05-3
- Omaveloxolone
- Keap1
- research grade trastuzumab biosimilar
- c-neu Monoclonal Antibody
- Human HER2 Monoclonal Antibody
- HER2 Monoclonal Antibody
- Human PD1 monoclonal antibody
- PD1 monoclonal antibody
- PD-1
- research grade Pembrolizumab biosimilar
- B7-H1
- PDL1
- CD274
- PD-L1
- PD-L1 monoclonal antibody
- anti-DNP monoclonal antibody
- DNP
- anti-DNP
- anti-mouse PD-L1 monoclonal antibody
- 10F.9G2
- anti-mouse pd-l1 antibody 10F.9G2
- anti-mouse pd-1 antibody 29F.1A12.1
- 29F.1A12.1
- PCR
- PCR enzyme
- cheap Taq enzyme
- Taq DNA Polymerase
- research grade biosimilar
- research grade cetuximab biosimilar
- EGFR
- EGFR Monoclonal Antibody
- Cetuximab Biosimilar
- anti-mouse PD-1 monoclonal antibody
- RMP1-14
- anti-mouse PD-1 monoclonal antibody RMP1-14
Who We Are
ushelf.com is a product and service distribution platform built by Syd Labs, Inc. which is located in Boston, Massachusetts, and dedicated to providing quality products and services for research and development in academy, industry, and government. We know how important quality is for your work and price for your business. We also know how hard it is to find a quality product or service from a reliable supplier. Welcome to let us know if you like or do not like which product, service, or supplier.